Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From empirical screening to lipid trolling: the evolution of extrahelical allosteric modulators of A<sub>1</sub> and A<sub>3</sub> adenosine receptors.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failure.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

Perturbing <i>O</i>-GlcNAcase Modulates the Expression and Distribution of Galectin-3.

Cells·2026
Same author

Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.

Breast cancer research : BCR·2026
Same author

Revisiting Hydrazine Moiety as a Scaffold for the Synthesis of Potential Antiviral Pyrazole Ribonucleoside Analogues.

ChemMedChem·2026
Same author

French Propolis Caffeic Acid Derivatives Protect Skeletal Muscle from Oxidative Damages.

Biomolecules·2026

Related Experiment Video

Updated: Jun 5, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.5K

Third-Generation CD73 Inhibitors Based on a 4,6-Disubstituted-2-Thiopyridine Scaffold.

Félix Grosjean1, Maria Shaldaeva2, Emeline Cros-Perrial3

  • 1Institut des Biomolécules Max Mousseron (IBMM), Pôle Chimie Balard, Univ. Montpellier, CNRS, ENSCM, 34293, Montpellier, France.

Chemmedchem
|December 13, 2024
PubMed
Summary

New thiopyridine derivatives were synthesized and tested as ecto-5'-nucleotidase (CD73) inhibitors. Some compounds effectively antagonized T-cell proliferation inhibition, showing potential therapeutic applications.

Keywords:
5’-ectonucleotidaseAdenosine receptorsEnzyme inhibitorMedicinal chemistryNitrogen heterocyclesThiopyridine

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K
Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

13.8K

Related Experiment Videos

Last Updated: Jun 5, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.5K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K
Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

13.8K

Area of Science:

  • Medicinal Chemistry
  • Immunology
  • Biochemistry

Background:

  • Ecto-5'-nucleotidase (CD73) is a key enzyme in purinergic signaling, often targeted in immune modulation.
  • T-cell proliferation is crucial for immune responses and can be modulated by CD73 activity.
  • Developing novel CD73 inhibitors is of interest for therapeutic interventions.

Purpose of the Study:

  • To synthesize and evaluate novel 4,6-disubstituted-2-thiopyridine derivatives as potential CD73 inhibitors.
  • To investigate the structure-activity relationships of these derivatives.
  • To assess their impact on T-cell proliferation and potential off-target effects.

Main Methods:

  • Synthesis of approximately ninety 4,6-disubstituted-2-thiopyridine derivatives.
  • Functional assay on immune cells to measure T-cell proliferation inhibition.
  • Inhibition assays on human adenosine A2A receptor (hA2A) in HEK-293 cells.

Main Results:

  • Several thiopyridine derivatives were synthesized using efficient one- or two-step procedures.
  • Compounds 4 9ab and 4 9ai demonstrated significant antagonism of T-cell proliferation inhibition at 100 μM and 10 μM concentrations.
  • These active compounds also exhibited moderate inhibition of the hA2A receptor in the micromolar range.

Conclusions:

  • The synthesized 4,6-disubstituted-2-thiopyridine derivatives show promise as CD73 inhibitors.
  • Compounds 4 9ab and 4 9ai possess dual activity, inhibiting CD73 and moderately affecting the hA2A receptor.
  • Further optimization could lead to more selective and potent inhibitors with reduced molecular size and lipophilicity.